The effect of non-benzodiazepine hypnotics on sleep quality and severity in patients with OSA: A meta-analysis

Sleep and Breathing

Volumn 18, Issue 4, 2014, Pages 781-789

  Zhang, Xiu Juan ^a,b   Li, Qing Yun ^a   Wang, Yan ^a   Xu, Hua Jun ^a   Lin, Ying Ni ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Insomnia; Meta analysis; Non benzodiazepine hypnotics; Obstructive sleep apnea; Sleep quality

Indexed keywords

EID: 84892867953     PISSN: 15209512     EISSN: 15221709     Source Type: Journal    
DOI: 10.1007/s11325-014-0943-7     Document Type: Article

References (38)

1. Luyster FS, Buysse DJ, Strollo PJ Jr (2010) Comorbid insomnia and obstructive sleep apnea: challenges for clinical practice and research. J Clin Sleep Med 6:196–204
2. Sivertsen B, Overland S, Glozier N, Bjorvatn B, Maeland JG, Mykletun A (2008) The effect of OSAS on sick leave and work disability. Eur Respir J 32:497–503
3. Krell SB, Kapur VK (2005) Insomnia complaints in patients evaluated for obstructive sleep apnea. Sleep Breath 9:104–110
4. Thurnheer R (2011) Diagnostic approach to sleep-disordered breathing. Expert Rev Respir Med 5:573–589
5. Drake CL, Day R, Hudgel D, Stefadu Y, Parks M, Syron ML et al (2003) Sleep during titration predicts continuous positive airway pressure compliance. Sleep 26:308–311
6. Lettieri CJ, Shah AA, Holley AB, Kelly WF, Chang AS, Roop SA et al (2009) Effects of a short course of eszopiclone on continuous positive airway pressure adherence: a randomized trial. Ann Intern Med 151:696–702
7. Pinto LR Jr, Alves RC, Caixeta E, Fontenelle JA, Bacellar A, Poyares D et al (2010) New guidelines for diagnosis and treatment of insomnia. Arq Neuropsiquiatr 68:666–675
8. Hanly P, Powles P (1993) Hypnotics should never be used in patients with sleep apnea. J Psychosom Res 37(Suppl 1):59–65
9. Dolly FR, Block AJ (1982) Effect of flurazepam on sleep-disordered breathing and nocturnal oxygen desaturation in asymptomatic subjects. Am J Med 73:239–243
10. Bezel R, Russi E, Kronauer H, Mothersill I (1987) Life-threatening apnea after midazolam administration in a patient with obstructive sleep apnea syndrome. Schweiz Med Wochenschr 117:579–583
11. Cirignotta F, Mondini S, Zucconi M, Gerardi R, Farolfi A, Lugaresi E (1988) Zolpidem-polysomnographic study of the effect of a new hypnotic drug in sleep apnea syndrome. Pharmacol Biochem Behav 29:807–809
12. Coyle MA, Mendelson WB, Derchak PA, James SP, Wilson MG (2005) Ventilatory safety of zaleplon during sleep in patients with obstructive sleep apnea on continuous positive airway pressure [Letter]. J Clin Sleep Med 1:97
13. Lettieri CJ, Collen JF, Eliasson AH, Quast TM (2009) Sedative use during continuous positive airway pressure titration improves subsequent compliance: a randomized, double-blind, placebo-controlled trial. Chest 136:1263–1268
14. Eckert DJ, Owens RL, Kehlmann GB, Wellman A, Rahangdale S, Yim-Yeh S et al (2011) Eszopiclone increases the respiratory arousal threshold and lowers the apnoea/hypopnoea index in obstructive sleep apnoea patients with a low arousal threshold. Clin Sci (Lond) 120:505–514
15. George CF, Feldman N, Inhaber N, Steininger TL, Grzeschik SM, Lai C et al (2010) A safety trial of sodium oxybate in patients with obstructive sleep apnea: acute effects on sleep-disordered breathing. Sleep Med 11:38–42
16. Lettieri CJ, Quast TN, Eliasson AH, Andrada T (2008) Eszopiclone improves overnight polysomnography and continuous positive airway pressure titration: a prospective, randomized, placebo-controlled trial. Sleep 31:1310–1316
17. Rosenberg R, Roach JM, Scharf M, Amato DA (2007) A pilot study evaluating acute use of eszopiclone in patients with mild to moderate obstructive sleep apnea syndrome. Sleep Med 8:464–470
18. Berry RB, Patel PB (2006) Effect of zolpidem on the efficacy of continuous positive airway pressure as treatment for obstructive sleep apnea. Sleep 29:1052–1056
19. Zucconi M, Ferini-Strambi L, Palazzi S, Orena C, Zonta S, Smirne S (1992) Habitual snoring with and without obstructive sleep apnoea: the importance of cephalometric variables. Thorax 47:157–161
20. Sato R, Malish S, Dickel GD, Hungs M, Sassoon C (2010) Hypnotics fail to improve polysomnographic quality and efficacy of CPAP titration [Abstract]. Chest 138:701A
21. Park JG, Olson EJ, Morgenthaler TI (2013) Impact of zaleplon on continuous positive airway pressure therapy compliance. J Clin Sleep Med 9:439–444
22. Collen J, Lettieri C, Kelly W, Roop S (2009) Clinical and polysomnographic predictors of short-term continuous positive airway pressure compliance. Chest 135:704–709
23. Bradshaw DA, Ruff GA, Murphy DP (2006) An oral hypnotic medication does not improve continuous positive airway pressure compliance in men with obstructive sleep apnea. Chest 130:1369–1376
24. Guilleminault C, Eldridge FL, Dement WC (1973) Insomnia with sleep apnea: a new syndrome. Science 181:856–858
25. Björnsdóttir E, Janson C, Gíslason T, Sigurdsson JF, Pack AI, Gehrman P, Benediktsdóttir B (2012) Insomnia in untreated sleep apnea patients compared to controls. J Sleep Res 21:131–138
26. Sériès F, Roy N, Marc I (1994) Effects of sleep deprivation and sleep fragmentation on upper airway collapsibility in normal subjects. Am J Respir Crit Care Med 150:481–485
27. Crestani F, Löw K, Keist R, Mandelli M, Möhler H, Rudolph U (2001) Molecular targets for the myorelaxant action of diazepam. Mol Pharmacol 59:442–445
28. Hajak G, Cluydts R, Declerck A, Estivill SE, Middleton A, Sonka K, Unden M (2001) Continuous versus non-nightly use of zolpidem in chronic insomnia: results of a large-scale, double-blind, randomized, outpatient study. Int Clin Psychopharmacol 17:9–17
29. Roth T, Walsh JK, Krystal A, Wessel T, Roehrs TA (2005) An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia. Sleep Med 6:487–495
30. Israel AG, Kramer JA (2002) Safety of zaleplon in the treatment of insomnia. Ann Pharmacother 36:852–859
31. Beaumont M, Batéjat D, Piérard C, Van Beers P, Philippe M, Léger D et al (2007) Zaleplon and zolpidem objectively alleviate sleep disturbances in mountaineers at a 3,613 meter altitude. Sleep 30:1527–1533
32. Girault C, Muir JF, Mihaltan F, Borderies P, Borderies P, De La Giclais B, Verdure A et al (1996) Effects of repeated administration of zolpidem on sleep, diurnal and nocturnal respiratory function, vigilance, and physical performance in patients with COPD. Chest 110:1203–1211
33. Quadri S, Drake C, Hudgel DW (2009) Improvement of idiopathic central sleep apnea with zolpidem. J Clin Sleep Med 5:122–129
34. Walsh JK, Pollak CP, Scharf MB, Schweitzer PK, Vogel GW (2000) Lack of residual sedation following middle-of-the-night zaleplon administration in sleep maintenance insomnia. Clin Neuropharmacol 23:17–21
35. Walsh JK, Vogel GW, Scharf M, Erman M, William Erwin C, Schweitzer PK et al (2000) A five week, polysomnographic assessment of zaleplon 10 mg for the treatment of primary insomnia. Sleep Med 1:41–49
36. Crestani F, Martin JR, Möhler H, Rudolph U (2000) Mechanism of action of the hypnotic zolpidem in vivo. Br J Pharmacol 131:1251–1254
37. Sanger DJ, Benavides J, Perrault G, Morel E, Cohen C, Joly D, Zivkovic B (1994) Recent developments in the behavioral pharmacology of benzodiazepine (omega) receptors: evidence for the functional significance of receptor subtypes. Neurosci Biobehav Rev 18:355–372
38. Ratnavadivel R, Chau N, Stadler D, Yeo A, McEvoy RD, Catcheside PG (2009) Marked reduction in obstructive sleep apnea severity in slow wave sleep. J Clin Sleep Med 5:519–524